3 ms·
Goldman Sachs asks: 'Is curing patients a sustainable business model?'
- HarryHirsch 9y agoThis is important: Goldman Sachs ask who is financing medical innovation and what should be financed for best returns. They do not say the FDA is bad for business, it's the medical field itself that has problems delivering returns.
- cmurf 9y agoIf companies are in fact amoral and are not compelled to be moral, and the only good is profit, then it is rational to conclude given the choice they would prefer development of a pill you have to take every day for the rest of your life, than a cure.